# A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

> **NCT06764615** · PHASE2 · RECRUITING · sponsor: **Takeda** · enrollment: 183 (estimated)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** Zasocitinib

## Key facts

- **NCT ID:** NCT06764615
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-28
- **Primary completion:** 2029-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 183 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06764615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06764615, "A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06764615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*